Contatti:
cell: +39 329 0364389
info@biomole.it
biomole@ALL RIGHT RESERVED 2019
FLU SARS-CoV-2
cod. BM-025
Principle of the test : Qualitative detection and differentiation of SARS-CoV-2 and Influenza A / Influenza B
Technology : One Step RT- PCR Real Time
Gene Target : N Nucleocapsid
Gene Target : M1 matrix gene Influenza A and NS2 nonstructural 2 gene Influenza B
Internal Control: GAPDH
Specimen : Respiratory specimens
Results : positive / negative
Number of tests : 50 tests BM-025 or kit 200 tests BM-025b
Kit storage : -20°C
Necessary equipment : 7500 Real Time PCR System or CFX96 Detection System
FLU SARS-CoV-2
The Influenza SARS-CoV-2 (Flu SARS-CoV-2) is a real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2 and influenza A virus / influenza B virus nucleic acid in respiratory specimens.
The Influenza SARS-CoV-2 (Flu SARS-CoV-2) is a multiplex assay, run in a single well/vessel, and is intended for use in the detection and differentiation of SARS-CoV-2 and influenza A/B viral RNA in patient specimens.
One Step Reverse Transcription Real Time polymerase chain reaction, the product contains oligonucleotide primers and dual-labeled
hydrolysis probes and control material used in rRT-PCR for the in vitro qualitative detection and differentiation of SARS-CoV-2 virus RNA, influenza A/B virus RNA. The oligonucleotide primers and probe for detection of SARS-CoV-2 were selected from an evolutionarily conserved region of the 3’ terminus of SARS-CoV-2 genome and include part or the carboxy-terminal portion of the nucleocapsid (N) gene. Primers and probes for the detection of influenza A viruses were selected from an evolutionarily well conserved region of the matrix (M1) gene. The primers and probe selected for detection of influenza B viruses were selected from a conserved region of the nonstructural 2 gene (NS2).